Cite
Seroprevalence and infection fatality rate of the SARS-CoV-2 Omicron variant in Denmark: A nationwide serosurveillance study.
MLA
Erikstrup, Christian, et al. “Seroprevalence and Infection Fatality Rate of the SARS-CoV-2 Omicron Variant in Denmark: A Nationwide Serosurveillance Study.” The Lancet Regional Health. Europe, vol. 21, Oct. 2022, p. 100479. EBSCOhost, https://doi.org/10.1016/j.lanepe.2022.100479.
APA
Erikstrup, C., Laksafoss, A. D., Gladov, J., Kaspersen, K. A., Mikkelsen, S., Hindhede, L., Boldsen, J. K., Jørgensen, S. W., Ethelberg, S., Holm, D. K., Bruun, M. T., Nissen, J., Schwinn, M., Brodersen, T., Mikkelsen, C., Sækmose, S. G., Sørensen, E., Harritshøj, L. H., Aagaard, B., … Pedersen, O. B. V. (2022). Seroprevalence and infection fatality rate of the SARS-CoV-2 Omicron variant in Denmark: A nationwide serosurveillance study. The Lancet Regional Health. Europe, 21, 100479. https://doi.org/10.1016/j.lanepe.2022.100479
Chicago
Erikstrup, Christian, Anna Damkjær Laksafoss, Josephine Gladov, Kathrine Agergård Kaspersen, Susan Mikkelsen, Lotte Hindhede, Jens Kjærgaard Boldsen, et al. 2022. “Seroprevalence and Infection Fatality Rate of the SARS-CoV-2 Omicron Variant in Denmark: A Nationwide Serosurveillance Study.” The Lancet Regional Health. Europe 21 (October): 100479. doi:10.1016/j.lanepe.2022.100479.